Keymed and Lepu Biopharma Jointly Announce Global Exclusive Licence Agreement with AstraZeneca for CMG901PRNewsWire • 02/23/23
AstraZeneca and Merck present final results of key secondary overall survival endpoint from Phase III PROpel trial at ASCO GU Cancers SymposiumBusiness Wire • 02/16/23
Rilvegostomig, AstraZeneca's Bi-specific Antibody Derived from Compugen's COM902, Expected to Progress into Phase 3PRNewsWire • 02/14/23
SOPHiA GENETICS Expands Partnership With AstraZeneca to Include Multimodal Approaches for Cancer Drug DevelopmentBusiness Wire • 02/13/23
AstraZeneca Stock Jumps As Upbeat Guidance Offsets Mixed Quarterly ReportInvestors Business Daily • 02/09/23
As demand for Covid vaccines falls, AstraZeneca lines up 'blockbuster' products for 2023CNBC • 02/09/23
AstraZeneca PLC modestly undershoots consensus in the fourth quarter; targeting low double digit sales growth this yearProactive Investors • 02/09/23
Top 5 Health Care Stocks That May Rally - AstraZeneca (NASDAQ:AZN), Amgen (NASDAQ:AMGN)Benzinga • 02/03/23